By Benjamin Horney ( December 22, 2015, 8:29 PM EST) -- Irish drugmaker Shire PLC has updated its bid to buy Baxalta Inc. in order to meet the U.S. biotech's valuation expectations, according to a Tuesday report from Reuters. According to the report, the new offer will likely be officially proposed within the coming weeks. Shire has added enough cash to its previously stock-only proposal in order to negotiations to advance, the report added. Shire first tried to buy Baxalta in July when it made a bid worth about $30 billion, but that offer was rejected as too low and untimely, though Shire has not been deterred....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.